GlaxoSmithKline requests emergency authorization from FDA for Covid antibody drug
GlaxoSmithKline and Vir Biotechnology applied for an emergency use authorization from the Food and Drug Administration for their monoclonal antibody drug. The companies are requesting clearance for use by high-risk … Read More